SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-010635
Filing Date
2013-06-20
Accepted
2013-06-20 08:27:24
Documents
1
Period of Report
2013-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5680
  Complete submission text file 0001179110-13-010635.txt   7221
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O GENAISSANCE PHARMACEUTICALS 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address
PENNER HARRY JR (Reporting) CIK: 0001131148 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15006 | Film No.: 13923345